Sofinnova Investments
Sofinnova is a clinical-stage biopharmaceutical venture capital firm with a focus on therapeutic drugs. They invest in both private and public equity companies across the U.S. and Europe, partnering with entrepreneurs to advance cures and improve lives. Their deep scientific knowledge is a core component of their investment strategy.
📥 Buy Full VC Dataset
Offices: Menlo Park (United States), Boston (United States), New York (United States)
Investment Stages: Series A, Series B
Markets: Biotechnology, Biopharmaceutical, Therapeutics, Oncology, Respiratory, Dermatology, Ophthalmology, Neurology, Women's Health, Cardiometabolic Diseases, Neuropsychiatric Disorders, Autoimmune Disorders, Metabolic Diseases, Orphan Diseases, Cardiovascular Diseases, Renal Diseases, Endocrine Diseases, Immuno-oncology, Pain Management, Genetic Disorders, Infectious Diseases, Gastroenterology, Hepatology
Founded Year: 1972
Investor Type: Venture Capital
Portfolio Companies: Axonis Therapeutics, Seaport Therapeutics, Capstan Therapeutics, Avenzo Therapeutics, BioAge Labs, OnCusp Therapeutics, Aiolos Bio, Star Therapeutics, Rapport Therapeutics, Alkeus Pharmaceuticals, ArriVent, Rayzebio, Gyroscope Therapeutics, Atsenatx, Vera Therapeutics, Visen Pharma, Aerovate Therapeutics, Bolt Biotherapeutics, Athira Pharma, Intrepid Bioscience, North Sea Therapeutics, Promedior, Aeovian, Karuna Therapeutics, CinCor Pharma, Inozyme Pharma, Quanta, XyloCor Therapeutics, Kiniksa, Neurana Pharmaceuticals, VelosBio, Akouos, Y-mAbs, Pionyr Immunotherapeutics, Medeor Therapeutics, Incarda Therapeutics, Dermavant Sciences, Seres Therapeutics, NextCure, Merus, Iterum Therapeutics, Entasis Therapeutics, Edge Therapeutics, Afyx Therapeutics, Dauntless Pharmaceuticals, Chiasma, Checkmate Pharmaceuticals, Rainier Therapeutics, Audentes Therapeutics, Atryx, Ascendis Pharma, Apellis Pharmaceuticals, Antiva Biosciences, Amplyx Pharmaceuticals, ZS Pharma, Versartis, Tesaro, Spark Therapeutics, Sophiris Bio, Sarcode Bioscience, Prothena, Principia Biopharma, Ophthotech, Obseva, NuCana, Natera, Synlogic, Biohaven, Innocoll, Histogenics, First Aid Shot Therapy, Civitas Therapeutics, Auris Medical, Alimera Sciences, Aclaris Therapeutics, Vicept Therapeutics, Trius Therapeutics, PregLem, Intellikine, Hyperion Therapeutics, Galerix, Coherus, C2N Diagnostics, Amarin, Aerie Pharmaceuticals, Orexigen, Mallinckrodt Pharmaceuticals, NextWave Pharmaceuticals, Marinus Pharmaceuticals, MedImmune, Catalyst Biosciences, Anthera Pharmaceuticals, Alvine Pharmaceuticals, Molecular Templates, Tensys Medical, Saegis Pharmaceuticals, Biovail, Humanigen, Actelion, Anesiva, Seattle Genetics, PharmaSonics, Intermune, Entelos, Actelion
Website: https://www.sofinnova.com
Team Page: https://www.sofinnova.com/people
Portfolio Link: https://www.sofinnova.com/portfolio/
LinkedIn: https://www.linkedin.com/company/sofinnova-ventures
Twitter: http://twitter.com/Sofinnova
Crunchbase: https://www.crunchbase.com/organization/sofinnova-ventures
Comments
No comments yet. Be the first to comment!